08/25/2026
Who is eligible for a new fluorescence-guided surgery clinical trial at Dartmouth Cancer Center (DCC), and what does participation involve?
"The trial is designed for patients who have been newly diagnosed with a high-grade glioma or glioblastoma and are preparing to have surgery," says Dartmouth Health neurosurgeon Linton T. Evans, MD. "One of the unique aspects of the trial is that it does not require additional travel for any other study visits. This is especially important for patients who live in a rural setting or travel hours to come to Dartmouth Hitchcock Medical Center. Because the study focuses on fluorescence during tumor removal, participation takes place all at the time of surgery. Patients continue receiving their standard care after surgery and can often have radiation or chemotherapy at a DCC location closer to home."